Showing results (2561-2570 of 6,717) with videos related to

Sort By:
Pageof 672
Oncotargets and Therapy|November 9, 2013
VEGF is a target molecule for peritoneal metastasis and malignant ascites in gastric cancer: prognostic significance of VEGF in ascites and efficacy of anti-VEGF monoclonal antibodySachio Fushida, Katsunobu Oyama, Jun Kinoshita, et al.
Oncotargets and Therapy|October 18, 2013
The emerging and diverse roles of sirtuins in cancer: a clinical perspectiveHongfeng Yuan, Leila Su, Wen Yong Chen
Oncotargets and Therapy|September 20, 2013
Emerging targets in pancreatic cancer: epithelial-mesenchymal transition and cancer stem cellsJason A Castellanos, Nipun B Merchant, Nagaraj S Nagathihalli
Oncotargets and Therapy|October 5, 2013
Impact of age on functional exercise correlates in patients with advanced lung cancerLi-Ying Wang, Huey-Dong Wu, Kuan-Yu Chen, et al.
Oncotargets and Therapy|October 5, 2013
IAP proteins as targets for drug development in oncologyLaurence Dubrez, Jean Berthelet, Valérie Glorian
Oncotargets and Therapy|August 1, 2013
Current status of bevacizumab in advanced ovarian cancerFederica Tomao, Anselmo Papa, Luigi Rossi, et al.
Oncotargets and Therapy|August 1, 2013
Clinical value of serum human epididymis protein 4 assay in the diagnosis of ovarian cancer: a meta-analysisZhijun Yang, Chunyin Wei, Zhaoqing Luo, et al.
Oncotargets and Therapy|July 10, 2013
Aberrant DNA methylation of ESR1 and p14ARF genes could be useful as prognostic indicators in osteosarcomaViviane Sonaglio, Ana C de Carvalho, Silvia R C Toledo, et al.
Oncotargets and Therapy|July 10, 2013
Long term results of sentinel lymph node biopsy in early oral squamous cell carcinomaDidier Dequanter, Mohammad Shahla, Pascal Paulus, et al.
Oncotargets and Therapy|July 23, 2013
Glycoprotein non-metastatic b (GPNMB): A metastatic mediator and emerging therapeutic target in cancerGordana Maric, April An Rose, Matthew G Annis, et al.
Pageof 672